Abstract Background About 828 million adults were estimated to be living with diabetes, and this is projected to affect 1 in 9 adults by 2045. In Belgium, 7.6% of adults have been diagnosed with the disease; however, approximately 1 in 3 people remain unaware of their condition. Advances in information and communicatio...
Barbara Annancy, S. A. Van den Bulck, S. Fieuws et al.· JMIR Research Protocols· 0 citations
BACKGROUND
For persons living with both type 2 diabetes and obesity, weight management may be the most effective therapy for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor agonists have potent weight-reducing effects, and other mechanisms may confer additional benefits. Survodutide is an investigational gluc...
Sean Wharton, C. L. le Roux, E. Startseva et al.· New England Journal of Medic...· 0 citations
Topics covered include selection criteria for management with diabetes technologies, CGM-derived glycaemic metrics and goals for adults with diabetes, insulin titration and administration guidelines, perioperative care, CGM alarm settings for hypoglycaemia and hyperglycaemia, clinical staff training and workflows, inte...
M. T. Olsen, E. Spanakis, H. Thabit et al.· Diabetologia· 0 citations
Topics covered include selection criteria for management with diabetes technologies, CGM-derived glycemic metrics and goals for adults with diabetes, insulin titration and administration guidelines, perioperative care, CGM alarm settings for hypoglycemia and hyperglycemia, clinical staff training and workflows, integra...
M. T. Olsen, E. Spanakis, H. Thabit et al.· Diabetes Care· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.